Patents Examined by John L Van Druff
  • Anti-Axl antagonistic antibodies
    Patent number: 11198734
    Abstract: The present disclosure relates to antibodies that specifically bind a novel epitope on the AxI protein. Also disclosed are methods for the production and use of the anti-Axl antibodies.
    Type: Grant
    Filed: June 21, 2017
    Date of Patent: December 14, 2021
    Assignees: Bergen Teknologioverføring AS, BerGenBio ASA
    Inventors: David Robert Micklem, Sergej Kiprijanov, James Bradley Lorens, Lavina Ahmed, Linn Nilsson, Tone Sandal
  • Antibody binding to TMEM132A, anticancer agent, and cancer test method
    Patent number: 11192956
    Abstract: [Problem] The present invention provides an antibody that binds to TMEM132A, an anticancer agent and a cancer test method. [Solution] An antibody that binds to TMEM132A.
    Type: Grant
    Filed: August 14, 2017
    Date of Patent: December 7, 2021
    Assignees: NATIONAL CANCER CENTER JAPAN, RIN INSTITUTE INC.
    Inventors: Yasuhiro Matsumura, Masahiro Yasunaga, Shinji Saijo, Shingo Hanaoka
  • Amino-acid-containing composition for enhancing recovery from muscle fatigue
    Patent number: 11077081
    Abstract: Administering an amino acid-containing composition, containing the following amino acids (1)-(9), wherein the molar content ratio of each amino acid to the total content of the amino acids (1)-(9) falls within the following numerical ranges: (1) leucine 35-66%; (2) isoleucine 5.0-15%; (3) valine 5.0-15%; (4) threonine 7.0-14%; (5) lysine 8.0-16%; (6) methionine 2.0-10%; (7) histidine 0.1-3.5%; (8) phenylalanine 2.5-8.0%; and (9) tryptophan 0.1-2.0%, is effective for enhancing recovery from muscle fatigue.
    Type: Grant
    Filed: February 7, 2014
    Date of Patent: August 3, 2021
    Assignee: AJINOMOTO CO., INC.
    Inventors: Hiroyuki Kato, Hisamine Kobayashi, Mayu Sugita, Hiromi Suzuki, Masako Mimura